Document is current

Article History

Received: 18 July 2022

Accepted: 2 January 2023

First Online: 10 January 2023

Declarations

:

: This study was approved by the New York University Langone Health institutional review board (19-01430).

: Not applicable.

: D.S.S., K.D.V., A.A., B.D., H.A., and G.G. have no competing interests to declare. E.J.S. declares the following financial and/or non-financial competing interests: American Academy of Orthopaedic Surgeons, American Orthopaedic Association, Arthrex, Inc, Arthroscopy Association of North America, Better PT, Cartiheal, Cartilage, Fidia, Flexion Therapeutics, Jaypee Publishing, Joint Restoration Foundation, Organogenesis, Smith & Nephew, Springer, Subchondral Solutions, Vericel, and Bulletin of the Hospital for Joint Diseases. M.J.A. declares the following financial and/or non-financial competing interests: American Academy of Orthopaedic Surgeons, Arthrex, Inc, Arthroscopy Journal, Arthroscopy Association of North America, Journal of Cartilage and Joint Preservation, JRF Ortho, Mitek, Orcosa, Inc, and Springer. L.M.J. declares the following financial and/or nonfinancial competing interests: Arthrex, Inc, Bulletin of the Hospital for Joint Diseases, JBJS Reviews, Mitek, Smith & Nephew, and Wolters Kluwer Health—Lippincott Williams & Wilkins. K.A.C. declares the following financial and/or non-financial competing interests: American Academy of Orthopaedic Surgeons, Arthroscopy Association of North America, Mitek, and Stryker.